Combining Alprazolam and Chlordiazepoxide: Risks and Precautions

Risks of Combination Therapy

Combining benzodiazepines with other CNS depressants substantially increases respiratory depression risk, with studies showing hypoxemia in up to 92% of subjects and apnea in 50% when benzodiazepines are combined with other sedating agents 1
Respiratory depression is dose-dependent and more likely in patients with underlying respiratory disease or those receiving multiple sedating medications 2
The risk of falls, particularly in elderly patients, is substantially elevated with multiple CNS depressants 1
Paradoxical behavioral disinhibition can occur, especially in younger children and those with developmental disabilities 3

If there is an unavoidable brief overlap during medication transition, use the lowest effective doses and limit duration to 24-48 hours maximum 4
Monitor closely for respiratory depression with pulse oximetry and cardiorespiratory monitoring 3
Observe for progressive sedation, which often precedes respiratory depression 4
Avoid in patients with baseline respiratory compromise (e.g. chronic obstructive pulmonary disease, sleep apnea) 1
Reduce doses by 50% or more in elderly patients 2
Ensure naloxone is immediately available, though it will not reverse benzodiazepine effects 2, 4